Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Failure of omalizumab in cholinergic urticaria
Clinical and Experimental Dermatology, 11/25/09
Sabroe RA – Cholinergic urticaria is one of the more common physical urticarias. Although it is often fairly mild, severe treatment–resistant disease may occur, with significant associated disability. Omalizumab, a monoclonal IgG anti–IgE antibody licensed for use in severe asthma, has recently been used successfully in several types of urticaria, including in one case of cholinergic urticaria.
Related Articles
An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment
Dermatologic Therapy, 11/20/09
Relevance Score: 88%
Chronic urticaria and treatment options
Indian Journal of Dermatology, 11/20/09
Relevance Score: 88%
The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations
Allergy, 11/16/09
Relevance Score: 88%
Solar urticaria
Allergy and Asthma Proceedings, 10/12/09
Relevance Score: 88%
Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria
British Journal of Dermatology, 10/05/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre
British Journal of Dermatology, 02/09/10
Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
Pediatric Rheumatology, 02/09/10
A phase 2A study of topical perillyl alcohol cream for chemoprevention of skin cancer
Cancer Prevention Research, 02/08/10
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Early exposure to solid foods and the development of eczema in children up to 4 years of age
Pediatric Allergy and Immunology, 02/09/10
Reduced IFN-gamma- and enhanced IL-4-producing CD4+ cord blood T cells are associated with a higher risk for atopic dermatitis during the first 2 yr of life
Pediatric Allergy and Immunology, 02/09/10
Quantitative Analysis of Eosinophils in Acute Graft-Versus-Host Disease Compared With Drug Hypersensitivity Reactions
American Journal of Dermatopathology, 02/08/10
Article Search
Sponsor
Sponsor


See Latest Articles


